Powerful and robust cross‐phenotype association test for case‐parent trios. Issue 5 (20th February 2018)

• Record Type: Journal Article
• Authors: Fischer, S. Taylor; Jiang, Yunxuan; Broadaway, K. Alaine; Conneely, Karen N.; Epstein, Michael P.
• Is Part Of: Genetic epidemiology. Volume 42:Issue 5(2018)
• Page Start: 447
• Page End: 458
• Publication Date: 2018-02-20
• Subjects: case‐parent trio design -- genetic association testing -- pleiotropy; Genetic epidemiology -- Periodicals; Heredity -- Periodicals; Medical geography -- Periodicals; 614
• DOI: 10.1002/gepi.22116
• Languages: English
• ISSNs: 0741-0395

Abstract

ABSTRACT: There has been increasing interest in identifying genes within the human genome that influence multiple diverse phenotypes. In the presence of pleiotropy, joint testing of these phenotypes is not only biologically meaningful but also statistically more powerful than univariate analysis of each separate phenotype accounting for multiple testing. Although many cross‐phenotype association tests exist, the majority of such methods assume samples composed of unrelated subjects and therefore are not applicable to family‐based designs, including the valuable case‐parent trio design. In this paper, we describe a robust gene‐based association test of multiple phenotypes collected in a case‐parent trio study. Our method is based on the kernel distance covariance (KDC) method, where we first construct a similarity matrix for multiple phenotypes and a similarity matrix for genetic variants in a gene; we then test the dependency between the two similarity matrices. The method is applicable to either common variants or rare variants in a gene, and resulting tests from the method are by design robust to confounding due to population stratification. We evaluated our method through simulation studies and observed that the method is substantially more powerful than standard univariate testing of each separate phenotype. We also applied our method to phenotypic and genotypic data collected in case‐parent trios as part of the Genetics of Kidneys in Diabetes (GoKinD) study and identified a genome‐wide significant gene demonstrating cross‐phenotype effects that was not identified using standard univariate approaches.